Dawn L. DeMeo Google Scholar: h-index, Total Citations, and Citation Map
Dawn L. DeMeo's h-index is 89 (251 i10-index, 32,357+ total citations across 100+ publications) according to Google Scholar as of October 2026. Dawn L. DeMeo is affiliated with Unknown affiliation.
Dawn L. DeMeo is a researcher affiliated with Unknown affiliation, specializing in COPD. Their work has been cited 32,357 times. This profile visualizes their global influence, highlighting strong citation networks in United States.
Dawn L. DeMeo's Citation Metrics
Bibliometric impact based on 100 indexed publications.
- H-Index
- 89
- i10-Index
- 251
- Total Citations
- 32,357
- Citing Countries
- 55
As of October 2026.
Dawn L. DeMeo has an h-index of 89 and 32,357 total citations across 100 publications, with research cited by institutions in 55 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Dawn L. DeMeo's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program
20212,649
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
The researcher established the clinical risk of lymphocytic choriomeningitis virus transmission via organ transplantation, a seminal finding published in the New England Journal of Medicine that has garnered over 600 citations.
The researcher led the sequencing of over 53,000 diverse genomes for the NHLBI TOPMed Program, establishing a foundational resource for large-scale genomic analysis.
The researcher published a seminal 2020 Lancet review establishing sex and gender as critical modifiers of health, disease, and medicine, achieving over 2,200 citations.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Dawn L. DeMeo's research
Dawn L. DeMeo is a researcher in COPD at Unknown affiliation. Their work has been cited 32,357 times across 100 publications (h-index 89), according to Google Scholar.
Their most-cited work, “Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program” (2021), has accumulated 2,649 citations. Other influential works include “Sex and gender: modifiers of health, disease, and medicine” (2020) with 2,419 citations and “DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis” (2016) with 1,097 citations.
Citations of Dawn L. DeMeo's research come primarily from United States, China and United Kingdom, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
